Ken Griffin Teva Pharmaceutical Industries LTD Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 3,956,700 shares of TEVA stock, worth $69.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,956,700

Previous 1,766,200 124.02%

Holding current value

$69.2 Million

Previous $24.9 Million 158.0%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $42.7 Million - $58.1 Million	-3,341,713 Reduced 65.39%	1,768,413 $28.7 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $69.3 Million - $93.7 Million	-6,493,437 Reduced 55.96%	5,110,126 $72.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $69.6 Million - $91.1 Million	8,573,014 Added 282.89%	11,603,563 $121 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $10.9 Million - $15.6 Million	-1,455,496 Reduced 32.44%	3,030,549 $30.9 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $36.5 Million - $48 Million	-5,065,306 Reduced 53.03%	4,486,045 $33.8 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $57.5 Million - $78.2 Million	6,879,779 Added 257.52%	9,551,351 $84.5 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $1.15 Million - $1.37 Million	144,815 Added 5.73%	2,671,572 $24.4 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $48.8 Million - $85.1 Million	-7,119,914 Reduced 73.81%	2,526,757 $20.4 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $57.4 Million - $80.9 Million	7,778,203 Added 416.29%	9,646,671 $72.5 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $3.7 Million - $4.74 Million	-505,182 Reduced 21.28%	1,868,468 $17.5 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $4.54 Million - $5.86 Million	-574,697 Reduced 19.49%	2,373,650 $19 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $749,088 - $909,990	-89,390 Reduced 2.94%	2,948,347 $28.7 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $10.7 Million - $12.5 Million	1,084,671 Added 55.54%	3,037,737 $30.1 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $5.98 Million - $7.41 Million	578,445 Added 42.08%	1,953,066 $22.5 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $7.6 Million - $9.75 Million	-882,701 Reduced 39.1%	1,374,621 $13.3 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $17.2 Million - $25.5 Million	2,005,712 Added 797.15%	2,257,322 $20.3 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $6.51 Million - $10.5 Million	-802,124 Reduced 76.12%	251,610 $3.1 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $8.02 Million - $16.1 Million	-1,198,779 Reduced 53.22%	1,053,734 $9.46 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $11.3 Million - $18.6 Million	1,734,238 Added 334.62%	2,252,513 $22.1 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $3.87 Million - $6.04 Million	-628,822 Reduced 54.82%	518,275 $3.57 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $4.81 Million - $9.32 Million	-592,724 Reduced 34.07%	1,147,097 $10.6 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $10.6 Million - $13.6 Million	-680,415 Reduced 28.11%	1,739,821 $0
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $4 Million - $6.54 Million	-274,342 Reduced 10.18%	2,420,236 $37.3 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $24.3 Million - $29.7 Million	1,156,121 Added 75.15%	2,694,578 $0
Q2 2018 Aug 10, 2018	BUY	$16.77 - $24.71 $19.7 Million - $29 Million	1,175,143 Added 323.45%	1,538,457 $0
Q1 2018 May 11, 2018	BUY	$16.68 - $22.07 $1.77 Million - $2.35 Million	106,321 Added 41.37%	363,314 $6.21 Million
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $2.79 Million - $4.74 Million	-248,172 Reduced 49.13%	256,993 $4.87 Million
Q3 2017 Nov 09, 2017	BUY	$15.41 - $32.17 $7.78 Million - $16.3 Million	505,165	505,165 $8.89 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account